We bring you the following message from European Medicines Agency (EMA):

“The EMA needs many detailed studies to confirm that a vaccine is safe, provides adequate protection and is of suitable quality. As a public-health body safeguarding medicines in the European Union (EU), EMA will only approve a vaccine for COVID-19 after a thorough evaluation demonstrating the same high standards of quality, safety and efficacy required for any other vaccine approved in the EU.”

Read more about Covid-19 vaccines on OIFE’s resource page on OI & Covid-19.